ASPI Stock Risk & Deep Value Analysis
ASP Isotopes Inc
Basic Materials • Chemicals
DVR Score
out of 10
What You Need to Know About ASPI Stock
We analyzed ASP Isotopes Inc using our deep value framework. Sign in to see our full verdict and DVR Score.
We ran ASPI through our deep value framework — analyzing financial health, distress signals, competitive moat, and risk factors. Our risk assessment: Aggressive. Here's what we found.
ASPI Risk Analysis & Red Flags
What Could Go Wrong
The delayed FY2025 10-K filing could reveal significant and unexpected financial issues, such as a lack of sufficient cash runway or accounting irregularities, leading to further capital requirements with heavy dilution, or a severe loss of investor confidence that tanks the stock price.
Risk Matrix
Overall
Aggressive
Financial
High
Market
Medium
Competitive
Medium
Execution
High
Regulatory
Medium
Red Flags
- ⚠
FY2025 10-K filing delayed as of March 31, 2026
- ⚠
Significant share dilution (-36.50% current shares buyback ratio)
- ⚠
Market capitalization declined ~42% since previous analysis despite operational news
- ⚠
Lack of comprehensive financial data (balance sheet, cash flow, profitability trends)
- ⚠
Trailing P/E of -2.75 indicating significant losses
Upcoming Risk Events
- 📅
Negative revelations or further delays in FY2025 10-K filing
- 📅
Operational delays or cost overruns for Virginia Gas Project or UK lithium collaboration
- 📅
Increased capital raises leading to further significant share dilution
- 📅
Unfavorable market conditions for helium or specialized isotope demand
When to Reconsider
- 🚪
Failure to file FY2025 10-K within the allowed 15-day extension period
- 🚪
Further share dilution exceeding 20% in a single quarter without proportional revenue growth
- 🚪
Significant and sustained operational delays in either the Virginia Helium Project or UK lithium initiative
- 🚪
Negative net cash flow from operations for two consecutive quarters without clear funding path
Unlock ASPI Risk Analysis & Red Flags
Create a free account to see the full analysis
What Does ASP Isotopes Inc (ASPI) Do?
Sector
Basic Materials
Industry
Chemicals
Employees
136
ASP Isotopes Inc., a development stage advanced materials company, engages in the production, distribution, marketing, and sale of isotopes. It operates in two segments, Nuclear Fuels, and Specialist Isotopes and Related Services. The Nuclear Fuels segment focuses on the research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market. Its Specialist Isotopes and Related Services segment engages in the research and development of technologies and methods used to separate high-value, low-volume isotopes, such as C-14, Mo-100 and Si-28, for target end markets, including pharmaceuticals and agrochemicals, nuclear medical imaging, and semiconductors; provision of related services; and operation of PET labs. The company offers the Aerodynamic Separation Process (ASP) technology, which separates gas species and isotopes in a volatile state; and the Quantum Enrichment (QE) technology, which separates isotopes. It also produces and commercializes Molybdenum-100, Molybdenum-98, and Ytterbium-176 for the nuclear medical industry. In addition, the company develops Zinc-67/68, Nickel-64, and Xenon 129/136 for the nuclear medical industry; Lithium-7, Uranium-235, and Chlorine-37 for the energy industry; and Germanium-70/72/74 for semiconductor markets. ASP Isotopes Inc. was incorporated in 2021 and is based in Washington, District Of Columbia.
Visit ASP Isotopes Inc WebsiteInvestment Thesis
ASP Isotopes represents a high-risk, high-reward bet on the commercialization of proprietary stable isotope separation technology and specialized energy projects. Its long-term potential in quantum computing, medical diagnostics, and nuclear energy, alongside near-term helium production, provides multiple growth vectors. Success hinges on resolving current financial transparency issues, executing on its projects to generate revenue, and effectively funding its capital-intensive endeavors without excessive dilution.
Is ASPI Stock Undervalued?
Unlock the full AI analysis for ASPI
Get the complete DVR score, risk analysis, and more
Unlock the full report
Create a free account to see the DVR score, risk flags, and AI analysis.
ASPI Price Targets & Strategy
12-Month Target
$8.00
Bull Case
$12.00
Bear Case
$2.00
Valuation Basis
Implied 1.5x market cap recovery ($0.8B to $1.2B) post-10K resolution and initial helium revenue, representing a speculative 2.2x 2026E P/S on projected $50M revenue (highly speculative given lack of data).
Entry Strategy
Consider dollar-cost averaging in the $3.50-$4.00 range, especially if positive news emerges regarding the 10-K filing and initial helium production. Monitor for sustained price stability after resolution of financial uncertainties.
Exit Strategy
Take profit on significant re-ratings (e.g., 20-30% gain from entry) given the high risk. Implement a stop-loss order at $2.50 to limit downside risk if negative news materializes or financial issues worsen.
Portfolio Allocation
1-3% for aggressive risk tolerance only. This is a highly speculative, high-risk position.
Price Targets & Strategy
Upgrade to Premium for price targets and entry/exit strategies
Is ASPI Financially Healthy?
Valuation
P/E Ratio
-2.75
Price/Book
7.40
Does ASPI Have a Competitive Moat?
Sign in to unlockMoat Rating
🛡️ Narrow
Moat Trend
Expanding
Moat Sources
3 Identified
The moat, primarily derived from its proprietary isotope separation technology, is durable due to the high barrier to entry (R&D, capital intensity, regulatory hurdles) in specialized isotope production. Continued innovation and successful commercialization will be key to its persistence.
Moat Erosion Risks
- •Technological obsolescence or emergence of superior alternative separation methods
- •Failure to scale production cost-effectively to meet demand
- •Intense competition from larger, more established industrial gas or specialty chemical companies if markets mature
- •Regulatory shifts or geopolitical risks affecting nuclear or critical materials industries
ASPI Competitive Moat Analysis
Sign up to see competitive advantages
ASPI Market Intelligence
Sentiment & Insider Activity
Social Sentiment
Neutral, with mixed sentiment likely skewed by recent price declines and lack of clear financial data.
Institutional Sentiment
Negative, evidenced by the substantial market cap decline and lack of analyst coverage.
Insider Activity (Form 4)
No specific Form 4 filings reported in last 90 days. The reported 0.00% float percentage appears to be a data anomaly.
Options Flow
Normal options activity (no specific data provided).
Earnings Intelligence
Next Earnings
2026-04-14 (for Q4 2025, but FY2025 10-K is delayed)
Surprise Probability
High (due to significant uncertainty around delayed financials and lack of recent data)
Historical Earnings Pattern
Insufficient data to establish a historical earnings reaction pattern due to company's stage and recent financial opacity.
Key Metrics to Watch
Competitive Position
Top Competitor
Not explicitly identified in real-time intelligence. Peers would likely be in niche stable isotope production (e.g., URENCO, NNSA), industrial gas suppliers (e.g., Linde for helium), or nuclear fuel companies.
Market Share Trend
Unknown. Company is likely aiming to create or expand niche markets rather than compete directly for existing market share in large, mature industries.
Valuation vs Peers
Undetermined due to lack of comprehensive financial data and specific peer comparisons. Its negative P/E suggests it trades at a significant discount on profitability metrics, as expected for an early-stage company.
Competitive Advantages
- •Proprietary technology for stable isotope enrichment (Intangible Assets/IP)
- •Strategic positioning in high-demand, critical material markets (e.g., quantum computing, medical isotopes, nuclear fuels)
- •Early mover advantage in specific niche applications
Market Intelligence
Get sentiment, earnings intel, and peer analysis with Premium
What Could Drive ASPI Stock Higher?
Near-Term (0-6 months)
- •FY2025 10-K filing and resolution of reporting delay (expected by mid-April 2026)
- •Q4 2025 Earnings Report (expected April 14, 2026)
- •Commencement of Phase 1 production from Virginia Gas Project (Helium/LNG) in 2026
Medium-Term (6-18 months)
- •Completion of initial design phase for UK lithium laser enrichment facility (initial 4 months from Q1 2026)
- •Securing major long-term contracts for stable isotopes or helium
- •Expansion of Virginia Gas Project production capacity
Long-Term (18+ months)
- •Demonstrated market leadership in specialized stable isotope segments (quantum computing, medical)
- •Successful commercialization of lithium enrichment technology for nuclear fuels
- •Disruption of existing industrial gas or specialty materials markets
Catalysts & Growth Drivers
Upgrade to Premium to see catalysts
What's the Bull Case for ASPI?
- ✓
Positive and timely resolution of the FY2025 10-K filing
- ✓
Consistent achievement of production targets for the Virginia Gas Project
- ✓
Announcement of significant long-term supply contracts for isotopes or helium
- ✓
Evidence of improving free cash flow or reduced cash burn
Bull Case Analysis
See what could go right with Premium
Competing with ASPI
See how ASP Isotopes Inc compares to related companies
| Company | Market Cap | DVR Score | P/E | Revenue | Profit Margin | Rev Growth | |
|---|---|---|---|---|---|---|---|
ASP Isotopes Inc ASPI | — | 4.3 | -2.8 | $8.4M | 0.0% | 0.0% | |
Air Products and Chemicals Inc APD | $65.8B | 1.2 | -197.5 | $12.0B | -2.7% | 1.4% | Compare → |
Freeport-McMoRan Inc FCX | $88.0B | 0.9 | 39.9 | $26.4B | 7.8% | -28.0% | Compare → |
Newmont Corporation NEM | $130.0B | 1.0 | 17.4 | $22.7B | 31.7% | 21.0% | Compare → |
📊 Explore More Stock Analysis
Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential with our AI-powered analysis.
How ASP Isotopes Inc Makes Money
ASP Isotopes (ASPI) is a technology company focused on producing highly enriched stable isotopes and other specialized materials for advanced industries. It generates revenue by applying its proprietary separation technology to create high-value isotopes used in quantum computing, medical diagnostics, and nuclear energy applications. Additionally, through its subsidiary, it is developing a project to produce and sell liquid helium and liquefied natural gas (LNG). The company also has initiatives in enriching lithium for nuclear fuels. Its business model relies on intellectual property, high-tech manufacturing, and specialized project development to serve critical, niche global markets.
Read Full Business Model BreakdownFAQ
What is the DVR Score for ASP Isotopes Inc (ASPI)?
As of April 10, 2026, ASP Isotopes Inc has a DVR Score of 4.3 out of 10, placing it in the "Proceed with Caution" category. This score is generated by our AI-powered deep value analysis framework that evaluates growth potential, financial health, competitive moat, and risk factors.
What ticker symbol does ASP Isotopes Inc use?
ASPI is the ticker symbol for ASP Isotopes Inc. The company trades on the NCM.
What is the risk level for ASPI stock?
Our analysis rates ASP Isotopes Inc's overall risk as Aggressive. This assessment considers execution risk, market risk, financial risk, competitive risk, and regulatory risk. For a full breakdown, see the risk analysis section above.
What is the P/E ratio of ASPI?
ASP Isotopes Inc currently has a price-to-earnings (P/E) ratio of -2.8. This is below the market average, which could indicate the stock is undervalued or facing headwinds.
Is ASP Isotopes Inc's revenue growing?
ASP Isotopes Inc has reported revenue growth of 0.0%. Revenue has been declining, which warrants closer examination.
Is ASPI stock profitable?
ASP Isotopes Inc has a profit margin of 0.0%. The company is currently unprofitable.
How often is the ASPI DVR analysis updated?
Our AI-powered analysis of ASP Isotopes Inc is refreshed regularly to incorporate the latest financial data, market conditions, and news. The most recent update was on April 10, 2026.
Important Disclaimer – Not Financial Advice
Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided on this page for ASPI (ASP Isotopes Inc) should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.
All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research, consider your financial situation, and consult with a qualified financial advisor before making any investment decisions.